Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132583) titled 'Using a Smart Medication Support System to Help Patients on New Dual-Target Immunotherapy Better Manage Treatment Side Effects' on Sept. 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fujian Cancer Hospital
Condition:
Non-small cell lung cancer (NSCLC)
Cervical cancer
Gastric or gastroesophageal junction adenocarcinoma
Intervention:
intervention group:On the basis of the control group, patients received individualized, comprehensive, and intelligent patient management interventions from pharmacists
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 202...